Accelerated Community Oncology Research Network, Inc. Surpasses 2007
MEMPHIS, Tenn., March 31 /PRNewswire/ -- The Accelerated Community Oncology Research Network, Inc. (ACORN), a national oncology clinical trial network, announced today that its Contract Research Organization (CRO) exceeded performance expectations over the past 12 months. ACORN's CRO provides the full range of research services to sponsors, from clinical trial design to site selection to the results phase with bioanalysis and findings presentation. "Sponsors have embraced the strength of ACORN CRO oncology focus. We are pleased that our activity in 2007 exceeded our projections and 1st Q 2008 appears equally impressive," remarked Steve Coplon, CEO.
Exclusively focused on oncology, ACORN CRO is backed by scientists and medical professionals dedicated to advancing cancer care through research. An important added strength resides in ACORN's network of community oncology researchers, specifically selected because of their commitment to oncology research and excellence in its execution. Close working relationships with demographically diverse US oncology practices result.
ACORN, Inc., a privately held company, significantly enhances the speed, accuracy, and productivity of conducting clinical research in the community oncology setting. Proactive project management with focused teams of clinical experts achieves these goals. Well-defined processes augmented by proprietary technology provide oversight and efficiencies on study functions for both pharma and participating sites.
Strong site relationships enable ACORN CRO to achieve enrollment targets within required timelines. Well-defined processes for site selection include comprehensive study-specific questionnaires, feasibility assessments, and expert evaluation of potential sites, ensuring a high probability of success for each study.
ACORN CRO project teams collaborate with sponsors and stay in close contact with investigator sites. Detailed communication, from kick-off meetings to weekly teleconferences to tracking each study ensures that sponsors are current with their study progress. Advanced technology enables comprehensive metrics reports for in-depth study status.
For additional information visit http://www.ACORNresearch.net or contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878.
Accelerated Community Oncology Research Network, Inc. (ACORN) ACORN
focuses on oncology exclusively. ACORN offers centralized clinical trial
services, scientific analysis, and is a full-service Clinical Research
Organization (CRO), providing contract and budgeting services; fostering
accrual of subjects at the site level; collecting data and monitoring its
accuracy; and working seamlessly with both trial sponsors and participating
Deborah D. Coble
|SOURCE Accelerated Community Oncology Research Network, Inc.|
Copyright©2008 PR Newswire.
All rights reserved